Ayan Chanda

674 total citations · 1 hit paper
15 papers, 424 citations indexed

About

Ayan Chanda is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Ayan Chanda has authored 15 papers receiving a total of 424 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 5 papers in Oncology and 3 papers in Cancer Research. Recurrent topics in Ayan Chanda's work include Ubiquitin and proteasome pathways (6 papers), Cancer-related Molecular Pathways (4 papers) and Cancer-related gene regulation (4 papers). Ayan Chanda is often cited by papers focused on Ubiquitin and proteasome pathways (6 papers), Cancer-related Molecular Pathways (4 papers) and Cancer-related gene regulation (4 papers). Ayan Chanda collaborates with scholars based in Canada, United States and Japan. Ayan Chanda's co-authors include Shirin Bonni, Pinaki Bose, Lili Deng, Subrata Kumar Biswas, Sambuddha Banerjee, Anjan Adhikari, T. Wayne Matthews, Mehul Kumar, Robert D. Hart and Joseph C. Dort and has published in prestigious journals such as Nature Communications, Journal of Neuroscience and PLoS ONE.

In The Last Decade

Ayan Chanda

15 papers receiving 417 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Spatial transcriptomics reveals distinct and conserved tumor core and edge architectures that predict survival and targeted therapy response

2023 120 citations Rohit Arora, Christian Cao et al. Nature Communications profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ayan Chanda Canada	10	273	161	103	70	28	15	424
Carlos Ortuño‐Pineda Mexico	12	246 0.9×	123 0.8×	103 1.0×	54 0.8×	23 0.8×	27	448
Chi‐Wei Chen Taiwan	11	278 1.0×	88 0.5×	82 0.8×	48 0.7×	37 1.3×	27	452
Chi-Kuan Chen Taiwan	13	311 1.1×	140 0.9×	161 1.6×	66 0.9×	33 1.2×	16	497
Margaret L. Thomas Canada	9	218 0.8×	137 0.9×	118 1.1×	64 0.9×	31 1.1×	11	348
Carina Walpole Australia	14	188 0.7×	123 0.8×	103 1.0×	116 1.7×	21 0.8×	28	502
Fangzhou Song China	11	209 0.8×	87 0.5×	58 0.6×	60 0.9×	19 0.7×	31	356
Amit Kumar Srivastava India	12	390 1.4×	133 0.8×	144 1.4×	37 0.5×	26 0.9×	24	492
Mohsen Karami Fath Iran	12	338 1.2×	105 0.7×	159 1.5×	61 0.9×	41 1.5×	28	496
Lakshmi Prabhu United States	11	439 1.6×	131 0.8×	147 1.4×	77 1.1×	31 1.1×	15	593
Ganchimeg Ishdorj Canada	13	250 0.9×	81 0.5×	67 0.7×	75 1.1×	21 0.8×	16	418

Countries citing papers authored by Ayan Chanda

Since Specialization

Citations

This map shows the geographic impact of Ayan Chanda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ayan Chanda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ayan Chanda more than expected).

Fields of papers citing papers by Ayan Chanda

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ayan Chanda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ayan Chanda. The network helps show where Ayan Chanda may publish in the future.

Co-authorship network of co-authors of Ayan Chanda

This figure shows the co-authorship network connecting the top 25 collaborators of Ayan Chanda. A scholar is included among the top collaborators of Ayan Chanda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ayan Chanda. Ayan Chanda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Chanda, Ayan, et al.. (2024). Targeting Oral Squamous Cell Carcinoma with Combined Polo-Like-Kinase-1 Inhibitors and γ-Radiation Therapy. Biomedicines. 12(3). 503–503. 1 indexed citations

Yang, Yang, Biao Ma, Qingrun Zhang, et al.. (2023). ING1 inhibits Twist1 expression to block EMT and is antagonized by the HDAC inhibitor vorinostat. European Journal of Cell Biology. 102(3). 151341–151341. 6 indexed citations

Chanda, Ayan, et al.. (2023). Sumoylated SnoN interacts with HDAC1 and p300/CBP to regulate EMT-associated phenotypes in mammary organoids. Cell Death and Disease. 14(7). 405–405. 5 indexed citations

Arora, Rahul K., Mehul Kumar, Steven C. Nakoneshny, et al.. (2023). NCBP2 and TFRC are novel prognostic biomarkers in oral squamous cell carcinoma. Cancer Gene Therapy. 30(5). 752–765. 19 indexed citations

Arora, Rohit, Christian Cao, Mehul Kumar, et al.. (2023). Spatial transcriptomics reveals distinct and conserved tumor core and edge architectures that predict survival and targeted therapy response. Nature Communications. 14(1). 5029–5029. 120 indexed citations breakdown →

Chanda, Ayan, et al.. (2020). PIAS1 and TIF1γ collaborate to promote SnoN SUMOylation and suppression of epithelial–mesenchymal transition. Cell Death and Differentiation. 28(1). 267–282. 10 indexed citations

Chanda, Ayan, et al.. (2020). Correction: PIAS1 and TIF1γ collaborate to promote SnoN SUMOylation and suppression of epithelial–mesenchymal transition. Cell Death and Differentiation. 28(5). 1753–1753. 9 indexed citations

Chanda, Ayan, et al.. (2020). TGF-β Mediated Immune Evasion in Cancer—Spotlight on Cancer-Associated Fibroblasts. Cancers. 12(12). 3650–3650. 62 indexed citations

Chanda, Ayan, Lili Deng, Gregory D. Jay, et al.. (2019). Recombinant human PRG4 (rhPRG4) suppresses breast cancer cell invasion by inhibiting TGFβ-Hyaluronan-CD44 signalling pathway. PLoS ONE. 14(7). e0219697–e0219697. 28 indexed citations

10.

Chen, Xiaoying, Ayan Chanda, Yoshiho Ikeuchi, et al.. (2018). The Transcriptional Regulator SnoN Promotes the Proliferation of Cerebellar Granule Neuron Precursors in the Postnatal Mouse Brain. Journal of Neuroscience. 39(1). 44–62. 12 indexed citations

11.

Chanda, Ayan, et al.. (2018). The SUMO System and TGFβ Signaling Interplay in Regulation of Epithelial-Mesenchymal Transition: Implications for Cancer Progression. Cancers. 10(8). 264–264. 21 indexed citations

12.

Chanda, Ayan, et al.. (2017). The PIAS3-Smurf2 sumoylation pathway suppresses breast cancer organoid invasiveness. Oncotarget. 8(13). 21001–21014. 35 indexed citations

13.

Chanda, Ayan, Angela Chan, Lili Deng, et al.. (2017). Identification of the SUMO E3 ligase PIAS1 as a potential survival biomarker in breast cancer. PLoS ONE. 12(5). e0177639–e0177639. 34 indexed citations

14.

Banerjee, Sambuddha, et al.. (2014). Evaluation of phytochemical screening and anti inflammatory activity of leaves and stem of Mikania scandens (l.) wild. Annals of Medical and Health Sciences Research. 4(4). 532–532. 58 indexed citations

15.

Biswas, Sudipta, et al.. (2011). Study of Microstructure and Mechanical Properties of Human Cortical Bone. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact